PL2801352T3 - Ulegające rozpadowi w jamie ustnej formulacje lakozamidu - Google Patents
Ulegające rozpadowi w jamie ustnej formulacje lakozamiduInfo
- Publication number
- PL2801352T3 PL2801352T3 PL14167375T PL14167375T PL2801352T3 PL 2801352 T3 PL2801352 T3 PL 2801352T3 PL 14167375 T PL14167375 T PL 14167375T PL 14167375 T PL14167375 T PL 14167375T PL 2801352 T3 PL2801352 T3 PL 2801352T3
- Authority
- PL
- Poland
- Prior art keywords
- lacosamid
- orally disintegrating
- disintegrating formulations
- formulations
- orally
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR201305490 | 2013-05-08 | ||
| TR201305664 | 2013-05-13 | ||
| EP14167375.6A EP2801352B1 (en) | 2013-05-08 | 2014-05-07 | Orally disintegrating formulations of Lacosamid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2801352T3 true PL2801352T3 (pl) | 2017-12-29 |
Family
ID=50630711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14167375T PL2801352T3 (pl) | 2013-05-08 | 2014-05-07 | Ulegające rozpadowi w jamie ustnej formulacje lakozamidu |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2801352B1 (pl) |
| ES (1) | ES2643287T3 (pl) |
| PL (1) | PL2801352T3 (pl) |
| WO (1) | WO2014180920A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3397253A1 (en) | 2015-12-30 | 2018-11-07 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of seizure-related disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090298947A1 (en) * | 2008-05-28 | 2009-12-03 | Pliva Hrvatska D.O.O. | Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| DE102008059155A1 (de) * | 2008-11-27 | 2010-06-02 | Ratiopharm Gmbh | Trockenverarbeitung und neue Formen von Lacosamid |
| WO2011055385A1 (en) * | 2009-11-03 | 2011-05-12 | Lupin Limited | Modified release formulation of lacosamide |
| WO2011130615A2 (en) * | 2010-04-15 | 2011-10-20 | Dr. Reddy's Laboratories Ltd. | Preparation of lacosamide |
| EP2468261A1 (en) * | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
-
2014
- 2014-05-07 PL PL14167375T patent/PL2801352T3/pl unknown
- 2014-05-07 EP EP14167375.6A patent/EP2801352B1/en active Active
- 2014-05-07 ES ES14167375.6T patent/ES2643287T3/es active Active
- 2014-05-07 WO PCT/EP2014/059375 patent/WO2014180920A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014180920A1 (en) | 2014-11-13 |
| EP2801352A1 (en) | 2014-11-12 |
| ES2643287T3 (es) | 2017-11-22 |
| EP2801352B1 (en) | 2017-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201501847B (en) | Formulations of enzalutamide | |
| GB201319791D0 (en) | Formulations | |
| GB201421334D0 (en) | Synthesis of aeizeolite | |
| IL240797A0 (en) | Defrasirox preparations for oral administration | |
| IL245855B (en) | Oral formulations of pyrrolidine derivatives | |
| GB201319792D0 (en) | Formulations | |
| IL245420A0 (en) | New formulations | |
| GB2539112B (en) | Chlorination of sucrose-6-esters | |
| ZA201505082B (en) | Sustained release formulations of lorazepam | |
| GB2516028B (en) | Improved structure of shoe | |
| PL2801352T3 (pl) | Ulegające rozpadowi w jamie ustnej formulacje lakozamidu | |
| PL2848260T3 (pl) | Nowe formulacje tiokolchikozydu | |
| TWM475821U (en) | Structure of mosquito-catch | |
| PL3071575T3 (pl) | Wytwarzanie normorfinanów | |
| GB201304608D0 (en) | BenTime of Yisrael operable arrangement | |
| TWM475524U (en) | Structure of rivet-pulling | |
| GB201322366D0 (en) | Chlorination of sucrose-6-esters | |
| GB201314779D0 (en) | Chlorination of sucrose-6-esters |